Home LiteratureArticle Details
PMID: 17290054 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Lung cancer incidence in never smokers.

Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK, West DW

Abstract

Lung cancer is a leading cause of cancer death worldwide. Although smoking remains the predominant cause of lung cancer, lung cancer in never smokers is an increasingly prominent public health issue. However, data on this topic, particularly lung cancer incidence rates in never smokers, are limited. We reviewed the existing literature on lung cancer incidence and mortality rates among never smokers and present new data regarding rates in never smokers from the following large, prospective cohorts: Nurses' Health Study; Health Professionals Follow-Up Study; California Teachers Study; Multiethnic Cohort Study; Swedish Lung Cancer Register in the Uppsala/Orebro region; and First National Health and Nutrition Examination Survey Epidemiologic Follow-Up Study. Truncated age-adjusted incidence rates of lung cancer among never smokers age 40 to 79 years in these six cohorts ranged from 14.4 to 20.8 per 100,000 person-years in women and 4.8 to 13.7 per 100,000 person-years in men, supporting earlier observations that women are more likely than men to have non-smoking-associated lung cancer. The distinct biology of lung cancer in never smokers is apparent in differential responses to epidermal growth factor receptor inhibitors and an increased prevalence of adenocarcinoma histology in never smokers. Lung cancer in never smokers is an important public health issue, and further exploration of its incidence patterns, etiology, and biology is needed.

MeSH Terms
Adenocarcinoma/epidemiology,etiology,mortality,pathology Adult Age Distribution Age Factors Aged Cohort Studies Female Humans Incidence Lung Neoplasms/epidemiology,etiology,mortality,pathology Male Middle Aged Prevalence Prospective Studies Registries Risk Factors Sex Distribution Sex Factors Smoking/adverse effects Sweden/epidemiology United States/epidemiology
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Wakelee Heather A
Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, USA. hwakelee@stanford.edu
Chang Ellen T
Gomez Scarlett L
Keegan Theresa H
Feskanich Diane
Clarke Christina A
Holmberg Lars
Yong Lee C
Kolonel Laurence N
Gould Michael K
West Dee W
References (69)
69 references, click to expand
  1. Contemporary lung cancer trends among U.S. women.
    Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):582-5 PMID: 15767333
  2. Epidemiology of lung cancer: looking to the future.
    J Clin Oncol. 2005 May 10;23(14):3175-85 PMID: 15886304
  3. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
    Cancer Res. 2005 Jun 15;65(12):5076-83 PMID: 15958551
  4. Erlotinib in previously treated non-small-cell lung cancer.
    N Engl J Med. 2005 Jul 14;353(2):123-32 PMID: 16014882
  5. Erlotinib in lung cancer - molecular and clinical predictors of outcome.
    N Engl J Med. 2005 Jul 14;353(2):133-44 PMID: 16014883
  6. Updated information on risk factors for lung cancer: findings from the JACC Study.
    J Epidemiol. 2005 Jun;15 Suppl 2:S134-9 PMID: 16127225
  7. Cancer surveillance research: a vital subdiscipline of cancer epidemiology.
    Cancer Causes Control. 2005 Nov;16(9):1009-19 PMID: 16184466
  8. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer).
    Lancet. 2005 Oct 29-Nov 4;366(9496):1527-37 PMID: 16257339
  9. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
    Carcinogenesis. 2005 Dec;26(12):2207-12 PMID: 16051642
  10. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors.
    J Clin Oncol. 2005 Nov 20;23(33):8396-405 PMID: 16293870
  11. Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokers.
    Ann Oncol. 2005 Dec;16(12):1906-14 PMID: 16219624
  12. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study.
    Mutat Res. 2005 Dec 30;592(1-2):45-57 PMID: 16009381
  13. Ethnic and racial differences in the smoking-related risk of lung cancer.
    N Engl J Med. 2006 Jan 26;354(4):333-42 PMID: 16436765
  14. Never smokers and lung cancer risk: a case-control study of epidemiological factors.
    Int J Cancer. 2006 Apr 1;118(7):1798-804 PMID: 16217766
  15. Calculating age-adjusted cancer survival estimates when age-specific data are sparse: an empirical evaluation of various methods.
    Br J Cancer. 2006 Feb 13;94(3):450-4 PMID: 16434986
  16. Cancer statistics, 2006.
    CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30 PMID: 16514137
  17. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
    Clin Cancer Res. 2006 Mar 1;12(5):1647-53 PMID: 16533793
  18. Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas.
    J Clin Oncol. 2006 Apr 10;24(11):1700-4 PMID: 16505411
  19. A combined analysis of North American case-control studies of residential radon and lung cancer.
    J Toxicol Environ Health A. 2006 Apr;69(7):533-97 PMID: 16608828
  20. Indoor radon and lung cancer risk in connecticut and utah.
    J Toxicol Environ Health A. 2006 Apr;69(7):633-54 PMID: 16608830
  21. Polymorphisms in the hMSH2 gene and the risk of primary lung cancer.
    Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):762-8 PMID: 16614121
  22. Lung cancer death rates in lifelong nonsmokers.
    J Natl Cancer Inst. 2006 May 17;98(10):691-9 PMID: 16705123
  23. Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer.
    Oncol Rep. 2006 Jul;16(1):183-9 PMID: 16786144
  24. Lung cancer in women: exploring sex differences in susceptibility, biology, and therapeutic response.
    Clin Lung Cancer. 2006 Jul;8(1):22-9 PMID: 16870042
  25. Radon, secondhand smoke, glutathione-S-transferase M1 and lung cancer among women.
    Int J Cancer. 2006 Sep 15;119(6):1462-7 PMID: 16642467
  26. Prognostic value of smoking status in operated non-small cell lung cancer.
    Lung Cancer. 2005 Mar;47(3):351-9 PMID: 15713518
  27. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics.
    Am J Epidemiol. 2000 Feb 15;151(4):346-57 PMID: 10695593
  28. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies.
    BMJ. 2000 Aug 5;321(7257):323-9 PMID: 10926586
  29. Lung cancer and arsenic concentrations in drinking water in Chile.
    Epidemiology. 2000 Nov;11(6):673-9 PMID: 11055628
  30. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women.
    J Natl Cancer Inst. 2000 Nov 15;92(22):1812-23 PMID: 11078758
  31. Growth rate of small lung cancers detected on mass CT screening.
    Br J Radiol. 2000 Dec;73(876):1252-9 PMID: 11205667
  32. Recent trends in lung cancer mortality in the United States.
    J Natl Cancer Inst. 2001 Feb 21;93(4):277-83 PMID: 11181774
  33. Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: Third National Health and Nutrition Examination Survey, 1988-1994.
    Am J Epidemiol. 2001 Apr 15;153(8):807-14 PMID: 11296155
  34. Incidence of lung cancer in a large cohort of non-smoking men from Sweden.
    Int J Cancer. 2001 Nov15;94(4):591-3 PMID: 11745449
  35. Occupational and environmental thoracic malignancies.
    J Thorac Imaging. 2002 Jul;17(3):189-97 PMID: 12082370
  36. High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States).
    Cancer Causes Control. 2002 Sep;13(7):625-35 PMID: 12296510
  37. Pathology of human bronchioloalveolar carcinoma and its relationship to the ovine disease.
    Curr Top Microbiol Immunol. 2003;275:225-48 PMID: 12596901
  38. Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years.
    Int J Epidemiol. 2003 Feb;32(1):60-3 PMID: 12690010
  39. Smoking verification and the risk of myocardial infarction.
    J Epidemiol Community Health. 2004 Feb;58(2):156; author reply 156-7 PMID: 14729900
  40. Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: a pooled analysis of two large studies.
    Int J Cancer. 2004 Mar10;109(1):125-31 PMID: 14735478
  41. Contribution of environmental factors to cancer risk.
    Br Med Bull. 2003;68:71-94 PMID: 14757710
  42. Occupation and lung cancer in nonsmokers.
    Rev Environ Health. 2003 Oct-Dec;18(4):251-67 PMID: 15025189
  43. Lung cancer rates in men and women with comparable histories of smoking.
    J Natl Cancer Inst. 2004 Jun 2;96(11):826-34 PMID: 15173266
  44. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung.
    Chest. 2004 Aug;126(2):347-51 PMID: 15302716
  45. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.
    Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13306-11 PMID: 15329413
  46. Lung adenocarcinoma and human papillomavirus infection.
    Cancer. 2004 Sep 15;101(6):1428-36 PMID: 15368331
  47. The cumulative risk of lung cancer among current, ex- and never-smokers in European men.
    Br J Cancer. 2004 Oct 4;91(7):1280-6 PMID: 15292933
  48. Prior lung disease and risk of lung cancer in a large prospective study.
    Cancer Causes Control. 2004 Oct;15(8):819-27 PMID: 15456995
  49. Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study.
    Am J Epidemiol. 1990 Jun;131(6):1068-71 PMID: 2343859
  50. Present and past smoking history and other predisposing factors in 100 lung cancer patients.
    Chest. 1992 Jan;101(1):19-25 PMID: 1729068
  51. Simple SAS macros for the calculation of exact binomial and Poisson confidence limits.
    Comput Biol Med. 1992 Sep;22(5):351-61 PMID: 1424580
  52. Surveillance for selected tobacco-use behaviors--United States, 1900-1994.
    MMWR CDC Surveill Summ. 1994 Nov 18;43(3):1-43 PMID: 7969014
  53. Lung cancer in nonsmoking women. Histology and survival patterns.
    Cancer. 1995 Jan 1;75(1):29-33 PMID: 7804973
  54. Lung cancer pathology in smokers, ex-smokers and never smokers.
    Cancer Lett. 1995 Jan 6;88(1):1-5 PMID: 7850764
  55. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States.
    Am J Epidemiol. 1995 Jun 1;141(11):1023-32 PMID: 7771438
  56. Ecologic studies in epidemiology: concepts, principles, and methods.
    Annu Rev Public Health. 1995;16:61-81 PMID: 7639884
  57. Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States.
    Am J Epidemiol. 1996 Mar 15;143(6):535-42 PMID: 8610670
  58. The Nurses' Health Study: 20-year contribution to the understanding of health among women.
    J Womens Health. 1997 Feb;6(1):49-62 PMID: 9065374
  59. Family history of cancer and risk of lung cancer in lifetime non-smokers and long-term ex-smokers.
    Int J Epidemiol. 1997 Apr;26(2):256-63 PMID: 9169159
  60. Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey.
    Am J Epidemiol. 1997 Aug 1;146(3):231-43 PMID: 9247007
  61. A European validation study of smoking and environmental tobacco smoke exposure in nonsmoking lung cancer cases and controls.
    Cancer Causes Control. 1998 Mar;9(2):173-82 PMID: 9578294
  62. Serum cotinine concentration and self-reported smoking during pregnancy.
    Am J Epidemiol. 1998 Aug 1;148(3):259-62 PMID: 9690362
  63. Misclassification rates for current smokers misclassified as nonsmokers.
    Am J Public Health. 1998 Oct;88(10):1503-9 PMID: 9772852
  64. Previous lung disease and risk of lung cancer among men and women nonsmokers.
    Am J Epidemiol. 1999 Jan 1;149(1):13-20 PMID: 9883789
  65. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking.
    J Natl Cancer Inst. 1999 Apr 21;91(8):675-90 PMID: 10218505
  66. Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan.
    JAMA. 2004 Dec 22;292(24):2984-90 PMID: 15613666
  67. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.
    Carcinogenesis. 2005 Feb;26(2):395-401 PMID: 15528218
  68. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies.
    BMJ. 2005 Jan 29;330(7485):223 PMID: 15613366
  69. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study.
    BMJ. 2005 Feb 5;330(7486):277 PMID: 15681570
Article Info
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Abbr.
J Clin Oncol
ISSN
1527-7755
Published
2007-02-10
Pages
472-8
Language
English
Region
United States
NLM ID
8309333
PMCID
PMC2764546
Subset
IM
Grants
NCI NIH HHS · P01 CA087969 · United States
NCI NIH HHS · P01 CA055075 · United States
NCI NIH HHS · R01 CA077398-09 · United States
NCI NIH HHS · N01 PC035136-21-0-0 · United States
NCI NIH HHS · R01 CA077398 · United States
NCI NIH HHS · R01 CA77398 · United States
NCI NIH HHS · P01 CA055075-09S10001 · United States
NCI NIH HHS · P01 CA087969-01 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com